High Dose Cholecalciferol to Reduce the Incidence of Gestational Diabetes in High Risk Pregnant Women

Withdrawn before enrolling · Phase 1/Phase 2

Conditions studied: Gestational Diabetes

In brief

Demonstrate dose-dependent relationship between vitamin D supplementation and rates of gestational diabetes.

Key facts

Study ID

NCT03037593

Run by

University of Minnesota

People needed

0

Starts

2017-06-01

Expected to finish

2020-06-01

Last updated by the study team

2019-11-01

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Women who are currently pregnant and receiving prenatal care at the Women's Health Specialists Clinic (University of Minnesota Physicians) from either MD/DO or CNM providers
• Subject established prenatal care no later than the completed 12th week of gestation (12 6/7 weeks)
• Subject possesses as least one of the following characteristics:
• BMI greater than or equal to 30 kg/m2
• History of gestational diabetes in a prior pregnancy
• History of infant with birth weight of 4500g or greater
• Subject is capable of giving informed consent

You may not qualify if…

• Age less than 18 years
• Multiple gestation pregnancies (twins, triplets or greater multiples)
• Vitamin D deficiency (defined as less than 20 ng/mL)
• Preexisting diabetes mellitus defined as either:
• pre-existing diagnosis prior to current pregnancy
• failure of three-hour glucose tolerance test in first trimester of pregnancy

Where it is running

• University of Minnesota Medical Center — Minneapolis, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.